← Back to Clinical Trials
Recruiting NCT05894005

NCT05894005 The Use of Immersive 360-degree Video in Improving Spatial Orientation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05894005
Status Recruiting
Phase
Sponsor Sunnybrook Health Sciences Centre
Condition Virtual Reality
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-11-08
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Immersive Virtual Reality (IVR)Traditional 2-D Video

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-11-08 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

As medical students rotate through different hospital sites as part of their studies, the students are frequently exposed to new and unfamiliar environments. This can cause anxiety in some students, and can potentially result in students becoming lost, and arriving late to their activities. To prevent this, students are currently provided with instructions in the form of written directions, photographs, maps, and/or 2-dimensional videos. In this study, the investigators will test if immersive 360-degree virtual reality videos (videos shown using a headset/goggles that allow the wearer to experience the video as though they were actually there), are better at teaching medical students how to navigate the hospital and find new locations, compared to normal, 2-dimensional video instructions. Medical students will be asked to find their way to a new location within the hospital, after being given instructions using either 2-dimensional (standard) video or 360-degree virtual reality video. The investigators will measure how long it takes students to find the new location, and how often the students get lost or confused along the way. If successful, the investigators believe that this new method of teaching will help students to get around in new places more easily and lessen student anxiety. This will also increase knowledge related to 360-degree virtual reality video for teaching medical students.

Eligibility Criteria

Inclusion Criteria: * Pre-clerkship (year 1 and 2) medical students from the University of Toronto, Temerty Faculty of Medicine. Exclusion Criteria: * Experience visiting Sunnybrook for personal reasons or previous coursework, shadowing, research, or clinical rotations. Having a familiarity with the floor plan of the hospital.

Contact & Investigator

Central Contact

Ahtsham U Niazi, FRCPC

✉ ahtsham.niazi@sunnybrook.ca

📞 647-339-0387

Principal Investigator

Ahtsham U Niazi, FRCPC

PRINCIPAL INVESTIGATOR

Sunnybrook Health Sciences Centre

Frequently Asked Questions

Who can join the NCT05894005 clinical trial?

This trial is open to participants of all sexes, studying Virtual Reality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05894005 currently recruiting?

Yes, NCT05894005 is actively recruiting participants. Contact the research team at ahtsham.niazi@sunnybrook.ca for enrollment information.

Where is the NCT05894005 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT05894005 clinical trial?

NCT05894005 is sponsored by Sunnybrook Health Sciences Centre. The principal investigator is Ahtsham U Niazi, FRCPC at Sunnybrook Health Sciences Centre. The trial plans to enroll 44 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology